HCPCS Level II J9076: Cyclophosphamide Injection, 5 mg (Baxter)
HCPCS Level II code J9076 describes an injection of cyclophosphamide (Baxter), 5 mg, used as an antineoplastic/chemotherapy agent; the service is administration of an intravenous chemotherapy drug (medication supply) typically provided in oncology infusion centers or hospital outpatient infusion settings and documented as a drug administration line item on outpatient medical claims.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J9076 policy alerts
Get alerted when payer policies referencing J9076 are released or updated.
Monitor payer policy activity